14 February 2017 // Partial Priorities // FICPI Official Visit - China
Partial Priority: Report on EPO Decision G1/15
On 1st February 2017 the Enlarged Board of Appeal of the EPO published the detailed reasoning supporting its earlier decision in case G1/15, which related to the manner in which partial priority applied to generic “OR”-claims.
The expression “generic “OR”-claim” was introduced by a Memorandum drafted by FICPI in 1973. The FICPI Memorandum is of particular importance in decision G1/15, as the FICPI Memorandum is recognised as setting out the legislative intent underlying Articles 88(2) and 88(3) EPC, which govern multiple and partial priorities.
The decision G1/15 now clarifies a situation where diverging case law had emerged before the Boards of Appeal of the EPO on how partial priority should be assessed for a generic claim. The decision should also bring an end to so-called “poisonous” priorities and "poisonous" divisional applications in Europe.
Importantly, this decision is fully in line with the position promoted by FICPI since 1973. The FICPI Memorandum is indeed confirmed by the decision as authoritative for assessing multiple and partial priorities, in particular for generic claims. The decision is also in full agreement with the amicus brief filed by FICPI on 29 February 2016 in this matter.
Official visits in China at the end of November 2016 further strengthened FICPI’s relationship with SIPO and extended the Federation’s reach in the field of trade marks in Asia by making a first visit to the Chinese Trademark Association (CTA). FICPI’s meetings with SIPO and CTA went deep into issues of Chinese patent and trade mark law, with members of the FICPI delegation presenting numerous issues of concern to private practitioners and their clients.
The full visit report is available on the FICPI website read more...
News in 2017
Do you have news from your country that the FICPI membership may be interested in? If so, please email communications@ficpi.org and request a copy of the FICPI Reporting Form.